Literature DB >> 15817363

Treatment planning of stereotactic radiotherapy for solitary lung tumor.

Kenji Takayama1, Yasushi Nagata, Yoshiharu Negoro, Takashi Mizowaki, Takashi Sakamoto, Masato Sakamoto, Tetsuya Aoki, Shinsuke Yano, Sachiko Koga, Masahiro Hiraoka.   

Abstract

PURPOSE: To analyze the stereotactic radiotherapy (SRT) plans in terms of internal target volume (ITV) and organs at risk (OARs). METHODS AND MATERIALS: Treatment planning and dose distributions were analyzed using dose-volume histograms (DVHs) of ITV and OARs in 37 patients, who were treated for a solitary lung tumor with SRT. The stereotactic body frame (SBF) was used for immobilization and accurate setup. Prescription dose was 48 Gy in four fractions at the isocenter.
RESULTS: Use of SBF limits the extent of the noncoplanar beam directions to prevent a collision with the Linac gantry. DVH analyses showed that the homogeneity index, defined as the ratio of maximum and minimum dose to ITV, ranged from 1.03 to 1.25 (mean, 1.12). The volume irradiated with 20 Gy or more (V(20)) of the lung ranged from 0.3 to 11.6% (mean, 4.4%) of the whole lung volume. The maximum dose to the other OARs ranged from 0 to 11.8 Gy (mean, 0.5-2.7) per fraction. No clinically significant complications were encountered.
CONCLUSIONS: Despite the limitation of the beam arrangement, a homogeneous target dose distribution, while avoiding high doses to normal tissues, was obtained.

Entities:  

Mesh:

Year:  2005        PMID: 15817363     DOI: 10.1016/j.ijrobp.2004.12.066

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  15 in total

1.  Stereotactic body radiotherapy for lung tumors at the pulmonary hilum.

Authors:  Yoshiko Oshiro; Takashi Aruga; Koji Tsuboi; Kan Marino; Ryusuke Hara; Yasushi Sanayama; Jun Itami
Journal:  Strahlenther Onkol       Date:  2010-04-26       Impact factor: 3.621

Review 2.  SBRT in operable early stage lung cancer patients.

Authors:  Johannes Roesch; Nicolaus Andratschke; Matthias Guckenberger
Journal:  Transl Lung Cancer Res       Date:  2014-08

3.  Safety and effectiveness of stereotactic body radiotherapy for a clinically diagnosed primary stage I lung cancer without pathological confirmation.

Authors:  Katsuyuki Sakanaka; Yukinori Matsuo; Yasushi Nagata; Sayo Maki; Keiko Shibuya; Yoshiki Norihisa; Masaru Narabayashi; Nami Ueki; Takashi Mizowaki; Masahiro Hiraoka
Journal:  Int J Clin Oncol       Date:  2013-11-12       Impact factor: 3.402

4.  Evaluation of mass-like consolidation after stereotactic body radiation therapy for lung tumors.

Authors:  Yukinori Matsuo; Yasushi Nagata; Takashi Mizowaki; Kenji Takayama; Takashi Sakamoto; Masato Sakamoto; Yoshiki Norihisa; Masahiro Hiraoka
Journal:  Int J Clin Oncol       Date:  2007-10-22       Impact factor: 3.402

5.  Beam's-eye-view imaging during non-coplanar lung SBRT.

Authors:  Stephen S F Yip; Joerg Rottmann; Ross I Berbeco
Journal:  Med Phys       Date:  2015-12       Impact factor: 4.071

6.  Exceptionally high incidence of symptomatic grade 2-5 radiation pneumonitis after stereotactic radiation therapy for lung tumors.

Authors:  Hideomi Yamashita; Keiichi Nakagawa; Naoki Nakamura; Hiroki Koyanagi; Masao Tago; Hiroshi Igaki; Kenshiro Shiraishi; Nakashi Sasano; Kuni Ohtomo
Journal:  Radiat Oncol       Date:  2007-06-07       Impact factor: 3.481

7.  Feasibility study of automated framework for estimating lung tumor locations for target-based patient positioning in stereotactic body radiotherapy.

Authors:  Satoshi Yoshidome; Hidetaka Arimura; Katsumasa Nakamura; Yoshiyuki Shioyama; Kazushige Atsumi; Yasuhiko Nakamura; Hideki Yoshikawa; Kei Nishikawa; Hideki Hirata
Journal:  Biomed Res Int       Date:  2015-01-05       Impact factor: 3.411

8.  Computer-aided beam arrangement based on similar cases in radiation treatment-planning databases for stereotactic lung radiation therapy.

Authors:  Taiki Magome; Hidetaka Arimura; Yoshiyuki Shioyama; Asumi Mizoguchi; Chiaki Tokunaga; Katsumasa Nakamura; Hiroshi Honda; Masafumi Ohki; Fukai Toyofuku; Hideki Hirata
Journal:  J Radiat Res       Date:  2012-12-18       Impact factor: 2.724

9.  Differences in the dose-volume metrics with heterogeneity correction status and its influence on local control in stereotactic body radiation therapy for lung cancer.

Authors:  Nami Ueki; Yukinori Matsuo; Keiko Shibuya; Mitsuhiro Nakamura; Masaru Narabayashi; Katsuyuki Sakanaka; Yoshiki Norihisa; Takashi Mizowaki; Masahiro Hiraoka
Journal:  J Radiat Res       Date:  2012-09-14       Impact factor: 2.724

10.  Similar-case-based optimization of beam arrangements in stereotactic body radiotherapy for assisting treatment planners.

Authors:  Taiki Magome; Hidetaka Arimura; Yoshiyuki Shioyama; Katsumasa Nakamura; Hiroshi Honda; Hideki Hirata
Journal:  Biomed Res Int       Date:  2013-11-02       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.